Agios Pharmaceuticals - 6 Year Stock Price History | AGIO

Historical daily share price chart and data for Agios Pharmaceuticals since 2013 adjusted for splits. The latest closing stock price for Agios Pharmaceuticals as of May 24, 2019 is 48.33.
  • The all-time high Agios Pharmaceuticals stock price is 135.01, which is 179.4% above the current share price.
  • The Agios Pharmaceuticals 52-week high stock price is 99.55, which is 106% above the current share price.
  • The Agios Pharmaceuticals 52-week low stock price is 42.73, which is 11.6% below the current share price.
  • The average Agios Pharmaceuticals stock price for the last 52 weeks is 67.68.
Agios Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 57.4121 47.2500 68.1000 45.9200 48.3300 4.81%
2018 76.7035 59.8300 99.5500 42.7300 46.1100 -19.35%
2017 55.5417 43.2200 72.3300 40.5100 57.1700 37.00%
2016 47.0693 63.6400 67.2500 35.7600 41.7300 -35.72%
2015 95.5307 109.7600 135.0100 48.6300 64.9200 -42.06%
2014 51.9120 24.0200 120.7800 22.5100 112.0400 367.81%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.838B $0.094B
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. It discovers and develops therapeutics in the field of cancer metabolism and inborn errors of metabolism. The Company's products include AG-221, AG-120, enzyme glutaminase and AG-348. Agios Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $135.807B 26.36
Medtronic (MDT) Ireland $124.767B 17.82
Stryker (SYK) United States $68.939B 24.60
Boston Scientific (BSX) United States $53.498B 25.65
Baxter (BAX) United States $38.314B 24.15
Zimmer Biomet Holdings (ZBH) United States $23.453B 15.07
Smith & Nephew SNATS (SNN) United Kingdom $18.518B 0.00
ResMed (RMD) United States $16.331B 31.20
Canopy Growth (CGC) Canada $15.286B 0.00
Bio-Rad Laboratories (BIO) United States $8.742B 46.35
Aurora Cannabis (ACB) Canada $8.427B 83.10
Hill-Rom Holdings (HRC) United States $6.498B 19.70
Insulet (PODD) United States $6.479B 472.04
Perrigo (PRGO) Ireland $6.439B 10.89
GW Pharmaceuticals (GWPH) United Kingdom $5.538B 0.00
Haemonetics (HAE) United States $5.172B 42.26
ICU Medical (ICUI) United States $4.652B 27.76
Hutchison China MediTech (HCM) China $3.574B 0.00
NuVasive (NUVA) United States $3.193B 26.07
Neogen (NEOG) United States $2.974B 48.36
National Vision Holdings (EYE) United States $2.257B 48.10
Quidel (QDEL) United States $2.184B 22.66
Aphria (APHA) $1.843B 0.00
HEXO (HEXO) $1.429B 0.00
Cardiovascular Systems (CSII) United States $1.376B 790.40
Phibro Animal Health (PAHC) United States $1.203B 18.02
AtriCure (ATRC) United States $1.140B 0.00
VAREX IMAGING (VREX) United States $1.042B 22.11
NanoString Technologies (NSTG) United States $0.973B 0.00
Lantheus Holdings (LNTH) United States $0.960B 25.49
MacroGenics (MGNX) United States $0.920B 0.00
Omeros (OMER) United States $0.876B 0.00
PetIQ (PETQ) United States $0.779B 18.92
Eagle Pharmaceuticals (EGRX) United States $0.756B 21.21
Cerus (CERS) United States $0.715B 0.00
TG Therapeutics (TGTX) United States $0.633B 0.00
Surmodics (SRDX) United States $0.572B 83.22
LeMaitre Vascular (LMAT) United States $0.524B 25.35
OraSure Technologies (OSUR) United States $0.509B 23.46
Quanterix (QTRX) United States $0.505B 0.00
Meridian Bioscience (VIVO) United States $0.477B 14.57
Evolus (EOLS) United States $0.440B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.336B 0.00
BioLife Solutions (BLFS) United States $0.330B 103.12
Utah Medical Products (UTMD) United States $0.302B 20.93
Vapotherm (VAPO) United States $0.284B 0.00
Rockwell Medical (RMTI) United States $0.272B 0.00
Zynex (ZYXI) United States $0.230B 23.80
Owens & Minor (OMI) United States $0.219B 4.64
Cytosorbents (CTSO) United States $0.213B 0.00
Bovie Medical (APYX) United States $0.198B 0.00
Chimerix (CMRX) United States $0.184B 0.00
Fonar (FONR) United States $0.130B 6.83
Chembio Diagnostics (CEMI) United States $0.120B 0.00
BRAINSWAY LTD (BWAY) Israel $0.118B 0.00
Female Health (VERU) United States $0.112B 0.00
Surface Oncology (SURF) United States $0.107B 0.00
InfuSystems Holdings (INFU) United States $0.099B 0.00
United-Guardian (UG) United States $0.091B 20.10
Neurotrope (NTRP) United States $0.091B 0.00
Insys Therapeutics (INSY) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.056B 19.33
Oramed Pharmaceuticals (ORMP) United States $0.051B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.039B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.028B 0.00
Myomo (MYO) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.006B 4.57